Multidomain Intervention Based on ICOPE
Key claim: FORMULA 100 will test whether an ICOPE-based multidomain care pathway screening for intrinsic-capacity decline and delivering a personalized 3-month intervention can be implemented in community-dwelling adults aged 65+ at Active Ageing Centers in Monza, Italy.
Abstract
FORMULA 100 is a prospective, single-arm feasibility study conducted at two Active Ageing Centers in Monza, Italy, involving community-dwelling adults aged 65 years and older. The study will test whether an Integrated Care for Older People (ICOPE)-based care pathway can be implemented in this setting.
Participants will first be screened for possible decline in intrinsic capacity (IC). Those enrolled will then undergo a multidimensional assessment and receive a personalized 3-month intervention tailored to their needs. The intervention may address physical, cognitive, nutritional, psychological, sensory, and social needs and may also include a review of medications.
Participants will be reassessed after 3 months and again after 6 months. The main study outcome is the proportion of participants who complete the 6-month follow-up. About 300 people are expected to be screened, with a target enrollment of 250 participants.
Why this matters
FORMULA 100 will test whether an ICOPE-based multidomain care pathway screening for intrinsic-capacity decline and delivering a personalized 3-month intervention can be implemented in community-dwelling adults aged 65+ at Active Ageing Centers in Monza, Italy.